BMC Cancer

Conclusions: Detection and characterization of CTCs by the presented approach was feasible and revealed heterogeneous gene expression in CTC fractions from early breast cancer

Perform a differential gene co-expressed analysis comparing breast tissue samples from healthy individuals and tissue samples taken adjacent to breast tumor, with normal histology,

The molecular characteristics of each breast cancer subtype were inferred from ATAC-seq and RNA-seq data from 70 breast cancer patients, using two different matrix

(52) demonstrated by studying gene expression profiles on different cell types in normal breast tissue, in situ carcinomas and invasive carcinomas that changes in gene

The overall tumor biology of breast cancer subtypes is highly dependent on the expression of estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth

Differential expression reveals novel breast-cancer associated miRNA We performed a differential expression analysis comparing clinically relevant subgroups of breast cancer.

Study the genome-wide expression of miRNAs in HER2+ breast cancer cell lines in relation to Trastuzumab response by searching for differentially expressed genes

The aim of this study has been to determine the ratio of matriptase to HAI-1 mRNA expression in affected and normal tissue from individuals with colorectal cancer